How should a ventricular septal defect identified on echocardiography be evaluated and managed?

Evaluation and Management of Ventricular Septal Defect on Echocardiography

Echocardiography is the definitive diagnostic tool for VSD evaluation, and you must systematically characterize the defect's type, size, number, hemodynamic significance, and associated complications to determine if intervention is needed. 1

Essential Echocardiographic Assessment

When a VSD is identified on echo, your evaluation must include these specific parameters 1, 2:

Anatomic Characterization

Defect Type (by location) 3:

• Perimembranous (membranous): Most common (77% of cases), located at the interventricular membranous septum, adjacent to atrioventricular and arterial valve continuity
• Muscular: Within trabeculated ventricular septum, can be multiple ("Swiss cheese" septum)
• Inlet: Opens into RV inlet component
• Outlet (supracristal): Opens to RV outflow tract between septal band limbs

Defect Quantification 3:

• Size: Measure maximal diameter in multiple views
  • Small: <25% of aortic annulus diameter (hemodynamically insignificant)
  • Moderate: 25-75% of aortic annulus diameter
  • Large: >75% of aortic annulus diameter
• Number: Single vs. multiple defects
• 3D echo provides superior sizing accuracy compared to 2D (mean bias of 4mm with 2D underestimation) 4

Hemodynamic Assessment

Critical measurements to obtain 1, 2:

• LV size and function: Look for volume overload from left-to-right shunt
• RV size and function: Assess for pressure/volume overload
• Pulmonary artery pressure:
  • Estimate from TR jet velocity
  • Calculate RV systolic pressure
  • Assess septal configuration (flattening suggests elevated PA pressure)
• Shunt direction and magnitude:
  • Color Doppler to confirm left-to-right flow
  • Calculate Qp:Qs ratio when possible
• VSD gradient: High-velocity jet (>4 m/s) indicates restrictive defect with preserved RV pressure

Associated Complications to Screen For

You must actively look for these 1, 5:

1. Aortic regurgitation: Occurs from aortic valve prolapse, especially with supracristal/outlet VSDs
2. RV outflow tract obstruction: Can develop over time (double-chambered RV)
3. LV outflow tract obstruction: Subaortic stenosis
4. Tricuspid regurgitation: Secondary to RV dilation
5. Pulmonary vascular disease: Eisenmenger physiology in unrepaired large VSDs

Management Algorithm

Indications for Intervention 1, 5

Proceed with closure if:

• Symptomatic patients with moderate-to-large VSD (heart failure, failure to thrive, recurrent respiratory infections)
• Qp:Qs ≥1.5:1 with evidence of LV volume overload
• Progressive aortic regurgitation from valve prolapse
• History of endocarditis
• Asymptomatic with significant left-to-right shunt causing RV/LV enlargement

Contraindications to closure:

• Pulmonary vascular resistance >8 Wood units/m²
• Qp:Qs <1.5:1 with elevated PVR
• Eisenmenger physiology (irreversible pulmonary vascular disease)

Intervention Strategy 6, 1

Surgical closure is preferred for:

• Perimembranous VSDs (due to high heart block risk with device closure)
• Supracristal/outlet VSDs
• Inlet VSDs
• Any VSD with aortic valve prolapse
• Infants requiring intervention

Percutaneous device closure can be considered for:

• Muscular VSDs only using Amplatzer Muscular VSD Occluder (good outcomes, lower complication risk) 6
• Avoid percutaneous closure of perimembranous VSDs - significant complete heart block risk (5-12% in studies) despite technical feasibility 7, 6

Small VSDs - Conservative Management 5, 8

For hemodynamically insignificant small VSDs:

• No intervention required
• Endocarditis prophylaxis for all VSDs (even small ones) 5
• Serial echo surveillance for:
  • Spontaneous closure (common in muscular VSDs, less so in perimembranous)
  • Development of aortic regurgitation
  • Changes in shunt magnitude
• No activity restrictions
• Follow-up intervals: infrequent unless complications develop

Critical Pitfalls to Avoid

1. Don't miss associated aortic regurgitation - examine aortic valve carefully in all supracristal and perimembranous VSDs 1

2. Don't confuse VSD jet with TR jet - can lead to incorrect PA pressure estimation 1

3. Don't assume small VSD = benign - monitor for double-chambered RV or subaortic stenosis development 1

4. Don't use 2D echo alone for device sizing - 3D echo significantly more accurate (r²=0.97 vs 0.63 for surgical correlation) 4

5. Don't attempt percutaneous closure of perimembranous VSDs outside specialized centers given heart block risk 6

Additional Imaging When Needed 1

Consider cardiac MRI or CT if:

• Poor echocardiographic windows in adults
• Unusual VSD location (inlet, apical muscular)
• Need to assess pulmonary/systemic venous anatomy
• Quantify shunt fraction when echo inadequate

Cardiac catheterization indicated when 1:

• Noninvasive data inconclusive
• Need to assess operability in patients with pulmonary hypertension (must be done at ACHD regional center)
• Calculate PVR and test pulmonary vasodilator response